Abstract
This study aimed to evaluate the impact of piperine on experimental autoimmune uveitis (EAU). EAU was induced by immunization with interphotoreceptor retinoid-binding protein emulsified in complete Freund adjuvant. Starting from day 8 post-induction, Lewis rats were given piperine (0, 20, 40, and 80mg/kg-P.O.) or prednisolone (10mg/kg-P.O.) for 18 consecutive days. The 80mg/kg dose of piperine demonstrated superior regression of clinical symptoms, increased nitric oxide levels, and enhanced IDO activity in eye homogenates compared to other doses. The 40 and 80mg/kg doses of piperine were more effective in promoting weight gain in EAU rats than the 20mg/kg dose. EAU rats treated with 80mg/kg piperine showed more favorable mRNA expression of IL-10 and TGF-β in their eyes than other treatment groups. The interventions led to a significant decrease in mRNA ratios of T-bet/GATA-3, RORγt/T-bet, RORγt/Foxp3, and RORγt/GATA-3 in the eyes of EAU rats compared to untreated EAU rats. Specifically, EAU rats treated with 80mg/kg piperine exhibited a greater reduction in the mRNA ratio of RORγt/Foxp3 expression compared to other treatment groups. Overall, oral administration of piperine may offer potential for clinical application in uveitis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
